Pettee Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$996K Hold
1,066
0.51% 55
2025
Q4
$1.15M Hold
1,066
0.64% 45
2025
Q3
$813K Hold
1,066
0.45% 64
2025
Q2
$831K Hold
1,066
0.5% 61
2025
Q1
$880K Hold
1,066
0.52% 60
2024
Q4
$823K Hold
1,066
0.42% 68
2024
Q3
$944K Hold
1,066
0.46% 67
2024
Q2
$965K Hold
1,066
0.47% 66
2024
Q1
$829K Sell
1,066
-264
-20% -$188K 0.35% 77
2023
Q4
$775K Hold
1,330
0.34% 78
2023
Q3
$714K Hold
1,330
0.34% 80
2023
Q2
$624K Hold
1,330
0.28% 83
2023
Q1
$457K Hold
1,330
0.22% 91
2022
Q4
$487K Buy
1,330
+130
+11% +$46.1K 0.24% 89
2022
Q3
$388K Hold
1,200
0.21% 93
2022
Q2
$389K Hold
1,200
0.19% 96
2022
Q1
$344K Hold
1,200
0.15% 103
2021
Q4
$331K Hold
1,200
0.14% 107
2021
Q3
$277K Hold
1,200
0.13% 112
2021
Q2
$275K Hold
1,200
0.13% 112
2021
Q1
$224K Buy
+1,200
New +$235K 0.11% 119

Other funds holding LLY

Pettee Investors's LLY Position: Q1 2026 in Review

Pettee Investors held its Eli Lilly (LLY) position steady in Q1 2026 at 1,066 shares worth $996K. The position accounts for 0.51% of the portfolio, ranked #55.

Pettee Investors first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.15M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pettee Investors held 1,066 shares of Eli Lilly worth $996K as of Q1 2026.
  • Pettee Investors left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.51% of Pettee Investors's portfolio in Q1 2026, its #55 holding.
  • Pettee Investors first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
  • Pettee Investors's Eli Lilly position peaked at $1.15M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pettee Investors's 13F filing for Q1 2026, filed 4 May 2026.